Model Number 3CX*FX25REC |
Device Problem
Obstruction of Flow (2423)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 11/04/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during prime, the sampling ramp, out going from the arterial connection was obstructed before the luer lock.No known impact or consequence to patient.The product was not changed out.The surgery was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report.Upon further investigation of the reported event, the following information is new and/or changed: (suspected medical device - corrected brand name), (device availability - added date returned to manufacturer), (date received by manufacturer) , (indication that this is a follow-up report) , (follow-up due to additional information).(device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.) all available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: (additional device information - added expiration date).(date received by manufacturer).(indication that this is a follow-up report).(follow-up due to additional information and device evaluation).(device evaluated by manufacturer).(device manufacture date).(b)(4).The affected sample was inspected upon receipt with a cloudy discoloration found at the pigtail line.Further reviewed found that the pigtail was obstructed by excessive bonding agent.Once the bonding agent was cleared, the pigtail flowed appropriately.A representative retention sample was reviewed with no physical obstructions in the sampling line.A general training was performed with the manufacturing associates to raise awareness to this issue.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|
|